American Transplant Congress 2011 Session List
Click here to search this conference.
Display sessions grouped by:
Track Session Code Speaker Date

Track

Conference Set
080: Pre-Meeting Symposium #1: Updates on Clinical and Technology Advances for the Transplant Scientist
081: Pre-Meeting Symposium #2: Essential Immunology for the Clinician
082: Pre-Meeting Symposium #3: Transplant Administrative Boot Camp Critical Elements: What Every Team Member Needs to Know
083: Pre-Meeting #4: The Troubled Renal Allograft - ARS (Don Hricik)
084: Pre-meeting #5: Leading Practices in Organ Donation and Preservation
085: Pre-meeting #6: Clinical Trials in Pediatric Solid Organ Transplantation
088: Pre-Meeting #7 : Essentials in Transplant Infectious Diseases: An Interactive Case-Based Session (ARS)
089: Pre-meeting #8: Update on Immunosuppression
090: Pre-meeting #9: Critical Care Issues in Liver Transplantation
091: Pre-meeting #10: Early Post Operative Complications
118: HIV & Transplantation: What Have We Learned and Where Are We Going?
119: CD8 Cells: Suppressors and Effectors
120: Controversies in Transplant Pharmacy Practice
121: Deceased Donor Kidney Utilization and the Prospect of Ex-Vivo Repair
122: Infection and Allograft Survival: "Indirect Effects"
123: Preclinical and Clinical Application of Regulatory T Cells in Transplantation Tolerance
124: T Cell Immunity in Clinical Practice
125: Tolerance in Clinical Transplantation through Mixed Chimerism: Update on Trials?
136: Joint Plenary and Award Session
139: Controversies in Transplantation Geographic Disparities in Liver Transplantation and Novel Approaches for Addressing Them
141: B Lymphocyte/Plasma Cell Homeostasis in Transplantation
142: Biomarkers as Diagnostic and Prognostic Tools in Organ Transplantation
143: New Insights in Fibrogenesis and Tissue Injury
144: Innovative Strategies to Protect the DCD Liver—ARS (Foley)
145: Update and Future Directions of New Immunosuppressive Therapies in Renal Transplantation
145A: Novel Antivirals in the Pipeline for HCV: Implications for Transplantation
146: Featured Symposium: Infectious Diseases Update for Pediatric Solid Organ Transplant Recipients
147: Featured Symposium: Xenotransplantation: Lessons for Allotransplantation
158: Transplantation in Depth: Antibody Mediated Rejection: Pathogenesis, Prevention and Treatment
172: Allied Health Symposium: Are We Speaking the Same Language? Transplant Education and Consent
211: Advances in Transplantation for the Diabetic, Uremic Transplant Candidate Through Sequential Kidney and Pancreas or Islet Transplantation
212: B Lymphocytes in Transplant Rejection and Tolerance
213: Beyond the SRTR Expected Outcomes: How Should We Determine the Adequacy of Solid Organ Transplant Programs'' Performance?
214: Donor-Derived Infections
215: Kidney Paired Donation: National Experience from US, Korea and Australia
216: The Emerging Field of Vascularized Composite Allotransplantation
217: Hepatitis C Infection after Liver Transplantation
218: Long Term Follow Up of the Living Donor: Ethics vs. Finance
226: Joint Plenary and Award Session
230: State-of-the-Art Address: Rebuilding Autologous Organs: Cells, Scaffold, Organ
234: ALDLT: An Update
235: Lymphodepletion and Reconstitution of the T Cell Repertoire
236: microRNAs: New Players in Gene Regulation, Tissue Injury and Rejection
237: Update on "Big Science" in Transplant
238: Viral Hepatitis in Solid Organ Transplantation
239: Featured Symposium: Improving Long-Term Survival in Thoracic Transplantation
240: Transplant Jeopardy
252: Transplantation in Depth: Tolerance is an Active Immunological Process: Part I and Part II
266: Allied Health Symposium: Living with an Organ Transplant in 2011: Management of Cardiovascular and Oncologic Co-Morbidity
311: The Critically Ill Lung Transplant Candidate: Clinical Management and Donor Selection
312: Barriers to the Recovery and Placement of High Risk Organs
313: What Every Clinician Should Know About Designing Better Transplant
314: Development of Small Molecules for Therapeutics
315: Immunosuppressive Agents and Infectious Disease
316: Memory T Cell Responses and Induction of Tolerance
317: The Multi-Disciplinary Approach to Hepatocellular Cancer
318: Renal Disease in Liver Transplantation
327: Joint Plenary and Award Session & ASTS Awards
329: State-of-the-Art Address: 2099: A Look Back at Tissue Engineering and Regenerative Medicine in the 21st Century
339A: FDA Symposium: FDA and Solid Organ Transplantation: Issues in the Practice of Medicine
353: Allied Health Symposium: Psychosocial Impact on Postoperative Transplant Outcomes
389: Role of Mechanical Circulatory Support in Heart Transplantation
390: Assessing the Risk for Kidney Allograft Failure
391: Bone Disease in Kidney Transplant Patients: What Diagnostic and Therapeutic Approaches Should We Use?
392: Donor Management: Organ Donation and Critical Care
393: Small Bowel Transplantation: The Basics
394: Stem Cell Mediated Therapy in Transplantation
404: Joint Plenary and Award Session
406: Keynote Address: The Not-So Distant Future of Organ Transplantation: Ethical Obstacles and Opportunities
417: What`s Hot, What`s New.

 

Conference Set

080: Pre-Meeting Symposium #1: Updates on Clinical and Technology Advances for the Transplant Scientist

Generating B Cell Responses and their Influence on Immune Responses Moderators: Olivia Martinez, PhD, Stanford University School of Medicine, Stanford, CA and Robert Fairchild, PhD, Cleveland Clinic Foundation, Cleveland, OH

081: Pre-Meeting Symposium #2: Essential Immunology for the Clinician

082: Pre-Meeting Symposium #3: Transplant Administrative Boot Camp Critical Elements: What Every Team Member Needs to Know

083: Pre-Meeting #4: The Troubled Renal Allograft - ARS (Don Hricik)

084: Pre-meeting #5: Leading Practices in Organ Donation and Preservation

085: Pre-meeting #6: Clinical Trials in Pediatric Solid Organ Transplantation

088: Pre-Meeting #7 : Essentials in Transplant Infectious Diseases: An Interactive Case-Based Session (ARS)

089: Pre-meeting #8: Update on Immunosuppression

090: Pre-meeting #9: Critical Care Issues in Liver Transplantation

091: Pre-meeting #10: Early Post Operative Complications

118: HIV & Transplantation: What Have We Learned and Where Are We Going?

Moderators: Barbara Murphy, MD, Mt. Sinai School of Medicine, New York, NY and Peter Chin-Hong, MD, University of California, San Francisco, CA

119: CD8 Cells: Suppressors and Effectors

Moderators: Alessandro Alessandrini, PhD, Massachusetts General Hospital, Boston, MA and Tatsuo Kawai, MD, Massachusetts General Hospital, Boston, MA

120: Controversies in Transplant Pharmacy Practice

Moderators: Alessandro Alessandrini, PhD, Massachusetts General Hospital, Boston, MA and Tatsuo Kawai, MD, Massachusetts General Hospital, Boston, MA

121: Deceased Donor Kidney Utilization and the Prospect of Ex-Vivo Repair

Moderators: Francis Delmonico, MD, Harvard Medical School, Boston, MA and Kevin O’Connor, MD, LifeCenter Northwest, Seattle, WA

122: Infection and Allograft Survival: "Indirect Effects"

Moderators: Atul Humar, MD, University of Alberta, Edmonton, Canada and Richard Freeman, MD, Dartmouth Medical School, Hanover, NH

123: Preclinical and Clinical Application of Regulatory T Cells in Transplantation Tolerance

Moderators: Li Zhang, MD, MSc, University Health Network, Toronto General Hospital, Toronto, Canada and Sandy Feng

124: T Cell Immunity in Clinical Practice

Moderators: Hans Hirsch and Martina Sester, PhD, University of the Saarland, Homburg, Germany

125: Tolerance in Clinical Transplantation through Mixed Chimerism: Update on Trials?

Moderators: Kenneth Brayman, MD, PhD, University of Virginia Health System, Charlottesville, VA and Suzanne Ildstad, MD, University of Louisville, Louisville, KY

136: Joint Plenary and Award Session

139: Controversies in Transplantation Geographic Disparities in Liver Transplantation and Novel Approaches for Addressing Them

Moderators: Krista Lentine, MD, St. Louis, MO and Goran Klintmalm, MD, PhD, Baylor Regional Transplant Institute, Dallas, TX

141: B Lymphocyte/Plasma Cell Homeostasis in Transplantation

Moderators: Michael Cancro, PhD, University of Pennsylvania, Philadelphia, PA and Anita Chong, PhD, University of Chicago, Chicago, IL

142: Biomarkers as Diagnostic and Prognostic Tools in Organ Transplantation

Moderators: Valeria Mas, PhD, Virginia Commonwealth University, Glen Allen, VA and Thomas Mueller, MD, University of Alberta, Edmonton, Canada

143: New Insights in Fibrogenesis and Tissue Injury

Moderators: Robert Fairchild, PhD, Cleveland Clinic Foundation, Cleveland, OH and Geetha Chalasani, PhD, University of Pittsburgh, Pittsburgh, PA

144: Innovative Strategies to Protect the DCD Liver—ARS (Foley)

Moderators: David Foley MD, University of Wisconsin, Madison, WI and John Renz, MD, PhD, University of Arizona, Tucson, AZ

145: Update and Future Directions of New Immunosuppressive Therapies in Renal Transplantation

Moderators: Bruce Kaplan, MD, AHSC, Tucson, AZ and Chris Larsen, MD, PhD, Emory University, Atlanta, GA

145A: Novel Antivirals in the Pipeline for HCV: Implications for Transplantation

146: Featured Symposium: Infectious Diseases Update for Pediatric Solid Organ Transplant Recipients

Moderators: Patricia Birk, MD, Children’s Hospital of Winnipeg, Winnipeg, Canada and Simon Horslen, MB, ChB, Seattle Children’s Hospital, Seattle, WA

147: Featured Symposium: Xenotransplantation: Lessons for Allotransplantation

Moderators: Gilles Benichou, MD, PhD, Massachusetts General Hospital, Boston, MA and Pierre Gianello, MD, PhD,

158: Transplantation in Depth: Antibody Mediated Rejection: Pathogenesis, Prevention and Treatment

Moderators: Stanley Jordan, MD, Cedars Sinai Medical Center, Los Angeles, CA and Mark Stegall, MD, Mayo Clinic, Rochester, MN

172: Allied Health Symposium: Are We Speaking the Same Language? Transplant Education and Consent

Moderators: Roxanne Taylor, RN, MSN, Maine Medical Center, Portland, ME and Ashley Seawright, DNP, ACNP-BC, University of Mississippi Health Care

211: Advances in Transplantation for the Diabetic, Uremic Transplant Candidate Through Sequential Kidney and Pancreas or Islet Transplantation

Moderators: David Axelrod and James Markmann, MD, PhD, Massachusetts General Hospital, Boston, MA

212: B Lymphocytes in Transplant Rejection and Tolerance

Moderators: Stuart Knechtle, MD, PhD, Emory University School of Medicine, Atlanta, GA and Richard Pierson, III, MD, University of Maryland, Baltimore, MD

213: Beyond the SRTR Expected Outcomes: How Should We Determine the Adequacy of Solid Organ Transplant Programs'' Performance?

Moderators: Kenneth Andreoni, MD, The Ohio State University, Columbus, OH and Bertram Kasiske

214: Donor-Derived Infections

Moderators: Shelly Morris, MD, University of Miami, School of Medicine, Miami Beach, FL and Paolo Grossi, MD, PhD, University of Insubria, Varese, Italy

215: Kidney Paired Donation: National Experience from US, Korea and Australia

Moderators: Edward Cole and Dorry Segev, MD, PhD, Johns Hopkins University, Baltimore, MD

216: The Emerging Field of Vascularized Composite Allotransplantation

Moderators: Stefan Tullius, MD, PhD, Brigham and Women’s Hospital, Boston, MA and Linda Cendales, MD, Emory University School of Medicine, Atlanta, GA

217: Hepatitis C Infection after Liver Transplantation

Moderators: Robert Fontana, MD, University of Michigan, Ann Arbor, MI and Robert Brown, Jr., MD, PhD, New York Presbyterian Hospital, New York, NY

218: Long Term Follow Up of the Living Donor: Ethics vs. Finance

Moderators: Cathy Garvey and Dianne Lapointe-Rudow

226: Joint Plenary and Award Session

230: State-of-the-Art Address: Rebuilding Autologous Organs: Cells, Scaffold, Organ

Doris Taylor, PhD

234: ALDLT: An Update

Moderators: Elizabeth Pomfret, MD, PhD, FACS, Lahey Clinic Medical Center, Burlington, MA and Jean Emond, MD, Columbia University Medical Center, New York, NY

235: Lymphodepletion and Reconstitution of the T Cell Repertoire

Moderators: Jonathan Bromberg, MD, PhD, University of Maryland, Baltimore, MD and Anna Valujskikh, PhD, The Cleveland Clinic Foundation, Cleveland, OH

236: microRNAs: New Players in Gene Regulation, Tissue Injury and Rejection

Moderators: Olivia Martinez, PhD, Stanford University School of Medicine, Stanford, CA and Anthony Jevnikar, MD, London Health Sciences Centre, University Hospital, London, Canada

237: Update on "Big Science" in Transplant

Moderators: Mohamed Sayegh, MD, Brigham & Women’s Hospital, Boston, MA and Ali Naji, MD, University of Pennsylvania Hospital, Philadelphia, PA

238: Viral Hepatitis in Solid Organ Transplantation

Moderators: Norah Terrault, MD, MPH, University of California, San Francisco, San Francisco, CA and James Trotter, MD, University of Colorado HSC, Aurora, CO

239: Featured Symposium: Improving Long-Term Survival in Thoracic Transplantation

Featured Symposium: Improving Long-Term Survival in Thoracic Transplantation

240: Transplant Jeopardy

Host: Jay Fishman Contestants: Michael Lucey, MD, University of Wisconsin Hospital & Clinic, Madison, WI, Dixon Kaufman, MD, Northwestern University Medical School, Chicago, IL and David Sutherland, MD, PhD, University of Minnesota Hospital, Minneapolis, MN

252: Transplantation in Depth: Tolerance is an Active Immunological Process: Part I and Part II

Moderators: Jonathan Bromberg, MD, PhD, University of Maryland, Baltimore, MD and Maria-Luisa Alegre, MD, PhD, University of Chicago, Chicago, IL

266: Allied Health Symposium: Living with an Organ Transplant in 2011: Management of Cardiovascular and Oncologic Co-Morbidity

Moderators: Margaret Bia, MD, Yale University School of Medicine, Guilford, CT and Deborah Adey, MD, University of Vermont, Burlington, VT

311: The Critically Ill Lung Transplant Candidate: Clinical Management and Donor Selection

Moderators: David Mason, MD, Cleveland Clinic Foundation, Cleveland, OH and David Zaas, MD, MBA, Duke University, Rochester, NY

312: Barriers to the Recovery and Placement of High Risk Organs

Moderators: Randall Sung, MD, University of Michigan Health System, Ann Arbor, MI and Herwig-Ulf Meier-Kreische, MD, University of Florida, Gainesville, FL

313: What Every Clinician Should Know About Designing Better Transplant

314: Development of Small Molecules for Therapeutics

Moderators: Alessandro Alessandrini, PhD, Massachusetts General Hospital, Boston, MA and Jonathan Maltzman, MD, PhD, University of Pennsylvania, Philadelphia, PA

315: Immunosuppressive Agents and Infectious Disease

Moderators: Emily Blumberg, MD, Hospital of the University of Pennsylvania, Philadelphia, PA and Camille Kotton, MD, Massachusetts General Hospital, Boston, MA

316: Memory T Cell Responses and Induction of Tolerance

317: The Multi-Disciplinary Approach to Hepatocellular Cancer

Moderators: Kevin Korenblat, MD, Washington University, St. Louis, MO and John Lake, MD, University of Minnesota, Minneapolis, MN

318: Renal Disease in Liver Transplantation

Moderators: Roy Bloom, MD, Hospital of the University of Pennsylvania, Philadelphia, PA and James Eason, MD, FACS, University of Tennessee—Methodist University Hospital, Memphis, TN

327: Joint Plenary and Award Session & ASTS Awards

329: State-of-the-Art Address: 2099: A Look Back at Tissue Engineering and Regenerative Medicine in the 21st Century

339A: FDA Symposium: FDA and Solid Organ Transplantation: Issues in the Practice of Medicine

Moderators: Patrick Archdeacon, MD, David Cohen and Robert Merion, MD, University of Michigan, Ann Arbor, MI

353: Allied Health Symposium: Psychosocial Impact on Postoperative Transplant Outcomes

Moderators: Cathy Garvey and Deborah Ann Hoch, DNP, Maine Medical Center, Portland, ME

389: Role of Mechanical Circulatory Support in Heart Transplantation

Moderators: Mariell Jessup, MD, Penn Institute for Immunology, Philadelphia, PA and Josef Stehlik

390: Assessing the Risk for Kidney Allograft Failure

Moderators: Michael Mengel, MD, University of Alberta, Edmonton, Canada and Fernando Cosio, MD, Mayo Clinic, Rochester, MN

391: Bone Disease in Kidney Transplant Patients: What Diagnostic and Therapeutic Approaches Should We Use?

Moderators: Margaret Bia, MD, Yale University School of Medicine, Guilford, CT and Michelle Josephson, MD, University of Chicago, Chicago, IL

392: Donor Management: Organ Donation and Critical Care

Moderators: Ginny McBride, MD, AMVAT Consulting, Grand Junction, CO and Ali Salim, MD, Cedars-Sinai Medical Center, Los Angeles, CA

393: Small Bowel Transplantation: The Basics

Moderators: Douglas Farmer, MD, Ronald Reagan UCLA Medical Center, Los Angeles, CA and George Mazariegos, MD, Children’s Hospital of Pittsburgh, Pittsburgh, PA

394: Stem Cell Mediated Therapy in Transplantation

Moderators: Robert Fairchild, PhD, Cleveland Clinic Foundation, Cleveland, OH and Anna Valujskikh

404: Joint Plenary and Award Session

406: Keynote Address: The Not-So Distant Future of Organ Transplantation: Ethical Obstacles and Opportunities

417: What`s Hot, What`s New.

Moderators: Michael Abecassis and Robert Gaston, MD, University of Alabama at Birmingham, Birmingham, AL